HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
ITRM holding history
Iterum Therapeutics plc in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITRM overviewAll 13F holders of ITRMFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q2 2025 | 3 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3 | $6 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3 | $5 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3 | $6 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3 | $0 | 0.0% | −0−10.0% | ReducedConverted for a 1-for-15 split | Holders |
| Q2 2022 | 50 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 50 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 50 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2021 | 50 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2021 | 50 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2021 | 50 | $0 | 0.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.